4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001493152-25-025224
VP of Research and Development acquired 152,672 shares (grant or award)
From the SEC's structured data for this filing
Kairos Pharma, LTD. Filed Acc 0001493152-25-025224
VP of Research and Development acquired 152,672 shares (grant or award)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…